Wellesley Investment Partners, LLC reports 0.74% decrease in ownership of GSK / GlaxoSmithKline plc
August 14, 2018 - Wellesley Investment Partners, LLC has filed a 13F-HR form disclosing ownership of 17,548 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $707,000 USD as of June 30, 2018. Wellesley Investment Partners, LLC had filed a previous 13F-HR on May 14, 2018 disclosing 17,678 shares of GlaxoSmithKline plc at a value of $690,000 USD. This represents a change in shares of -0.74 percent and a change in value of 2.46 percent during the quarter.
Other investors with positions similar to Wellesley Investment Partners, LLC include Kcs Wealth Advisory, Fiduciary Trust Co, Ballentine Partners, LLC, Old National Bancorp /in/, Ramsay, Stattman, Vela & Price, Inc., and MAVEN SECURITIES Ltd.
The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.
In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.
Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.
as of ET